Contact Supplier

Contact Supplier

To get in touch with Evercyte GmbH, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

Evercyte and Boehringer Ingelheim to investigate EVs for NextGen therapies

Evercyte GmbH News Releases

Find the latest News from Evercyte GmbH

Home / News Releases

Evercyte and Boehringer Ingelheim to investigate EVs for NextGen therapies

Sunday 24th February 2019

By Evercyte GmbH Learn More >

Evercyte brings new human cell line development solutions to 3Rs Days

Sunday 17th February 2019

By Evercyte GmbH Learn More >

Evercyte hosting Altertox Training Workshop on GCCP in Toxicology

Wednesday 17th October 2018

By Evercyte GmbH Learn More >

Evercyte brings new human cell line development solutions to in-vitro toxicology at ESTIV Berlin

Friday 5th October 2018

By Evercyte GmbH Learn More >

Evercyte showing human telomerized cell alternatives at Alternatives to Animal Testing Congress

Tuesday 18th September 2018

By Evercyte GmbH Learn More >

Evercyte showing expanded biotech cell offers at BIO International

Friday 1st June 2018

By Evercyte GmbH Learn More >

Evercyte bringing range of new offers to ToxExpo 2018

Wednesday 7th March 2018

By Evercyte GmbH Learn More >

Evercyte hosts Season 2 of kidney toxicity training

Wednesday 4th October 2017

By Evercyte GmbH Learn More >

Evercyte brings innovative hTERT immortalized human podocyte cell line to Eurotox 2017

Tuesday 29th August 2017

By Evercyte GmbH Learn More >

Evercyte posting novel hTERT immortalized human podocytes cell line modeling at WC10 Seattle

Monday 7th August 2017

By Evercyte GmbH Learn More >

Evercyte discussing human podocytes in cell-based screening at ELRIG CBS 2017

Tuesday 9th May 2017

By Evercyte GmbH Learn More >

Evercyte bringing range of offers to ToxExpo 2017

Tuesday 28th February 2017

By Evercyte GmbH Learn More >